Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02153931
Recruitment Status : Completed
First Posted : June 3, 2014
Last Update Posted : January 31, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

Brief Summary:

Background:

- Studies show that Internet Support Groups (ISGs) can help parents of children with chronic conditions. Researchers want to find out if ISGs can help parents of a child with the genetic disorder Neurofibromatosis Type 1 (NF1).

Objective:

- To see if an ISG for parents with a child with NF1 can give the parents more social support and less anxiety.

Eligibility:

- Adults age 18 and older with a child (age 0 25 years) with NF1.

Design:

  • Participants will register for the study on a website hosted by the Children s Tumor Foundation.
  • Participants will complete 5 questionnaires. These will be about their emotional well-being, their child s health status, and their contact information.
  • The ISG will include a Discussion Forum that participants can enter 24 hours a day, 7 days a week. A professional moderator will post questions and discussion topics. The moderator can also respond to questions. They will be a psychologist, a psychology associate, or a nurse-practitioner. Each one will be highly experienced at working with young people with NF1 and their families.
  • The ISG also will contain a chat room. Here participants can chat with other users in real time. The chat room will be open for one 90-minute session per week.
  • The ISG will remain open for 8 weeks. Then participants will retake 4 of the questionnaires from the beginning of the study. They will also complete 1 other questionnaire about their experiences with the ISG. Information from any messages participants post on the ISG website will be collected.
  • Three months after the ISG closes, participants will complete the questionnaires one final time.

Condition or disease
Neurofibromatosis 1

Detailed Description:

BACKGROUND:

  • The complex symptom profile in NF1 puts children and adolescents with this condition at risk for a variety of physical, cognitive, and social-emotional difficulties. Thus, caring for a child with a chronic medical condition such as NF1 can be challenging.
  • Over the last two decades, researchers have been examining the use of internet support groups (ISGs) as a means of connecting individuals with similar conditions, diagnoses, or challenges to provide emotional and informational support.
  • While the benefits of ISGs have been well documented in many studies of medical patients, very few have examined the use of ISGs in parents of children with chronic medical conditions. Further, no studies have been conducted on an ISG in parents of a child with NF1.

OBJECTIVES:

  • The primary objective of this pilot study is to assess the effectiveness of an ISG designed for parents of children with NF1 on a measure of perceived social support.
  • Secondary objectives are to assess effects of the ISG on self-efficacy, depression, and anxiety, and to explore themes and topics discussed in the ISG.

ELIGIBILITY:

Eligible participants must self-report:

  • Being greater than or equal to 18 years of age
  • Having a child with a diagnosis of NF1 between 0 and 25 years of age
  • Living in the same home as the child with NF1

    • Having regular access to a computer with internet capability

DESIGN:

  • Parents of children with NF1 will be recruited through Dr. Widemann s NF1 patient database and through the Children s Tumor Foundation s (CTF) NF registry.
  • Eligible participants will be emailed a link to access the study website through the CTF website. Due to the nature of the study, consent will be obtained online.
  • After consenting, participants will be administered (electronically) baseline measures of perceived social support, self-efficacy, depression, and anxiety. After 8 weeks, participants will complete the measures again via the same website, as well as a post-study questionnaire assessing their experiences with participation. Measures will be repeated at 3-months post-intervention.
  • Content analyses will be performed to identify themes and needs of the participants

Layout table for study information
Study Type : Observational
Actual Enrollment : 33 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Effects of an Internet Support Group for Parents of a Child With Neurofibromatosis Type 1
Study Start Date : May 31, 2014
Actual Primary Completion Date : April 6, 2015
Actual Study Completion Date : January 29, 2019


Group/Cohort
Volunteers
Parents of children with NF1



Primary Outcome Measures :
  1. ISG effects on perceived support [ Time Frame: 3 months ]
    To determine the effects of an ISG on perceived social support among parents of a child with NF1 from baseline to 8 weeks and frombaseline to 3 months postintervention.


Secondary Outcome Measures :
  1. ISG effects on depression and anxiety [ Time Frame: 3 months ]
    To determine the effects of an ISG on perceived social support among parents of a child with NF1 from baseline to 8 weeks and frombaseline to 3 months post-intervention.

  2. Identify themes and needs of chat room support [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
  • ELIGIBILITY CRITERIA

INCLUSION CRITERIA FOR PARENT PARTICPANT:

Participants must self-report being the primary caregiver of one or more children ages 0 to 25 with a confirmed diagnosis of NF1.

Participants must report being at least 18 years of age.

Participants must report living in the same home as the child(ren) with NF1 a majority of the time.

Participants must report having regular access to a computer and internet connection.

Participants will indicate they do not have any plans to start any other internet support group for parents of children with NF during the study time period.

Participants must have the ability to read and communicate in the English language.

Participants must have the ability to understand and the willingness to provide an online informed consent document.

EXCLUSION CRITERIA FOR PARENT PARTICIPANT:

Although individuals will be allowed to participate if they currently are part of another internet forum for NF, they will be excluded if they report they plan to start a new internet support group during the study period.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02153931


Locations
Layout table for location information
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Cancer Institute (NCI)
Investigators
Layout table for investigator information
Principal Investigator: Staci M Peron, Ph.D. National Cancer Institute (NCI)

Layout table for additonal information
Responsible Party: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT02153931     History of Changes
Other Study ID Numbers: 140113
14-C-0113
First Posted: June 3, 2014    Key Record Dates
Last Update Posted: January 31, 2019
Last Verified: January 29, 2019
Keywords provided by National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ):
Children's Tumor Foundation
Social Support
Online
Anxiety
Depression
Additional relevant MeSH terms:
Layout table for MeSH terms
Neurofibromatoses
Neurofibromatosis 1
Neurofibroma
Nerve Sheath Neoplasms
Neoplasms, Nerve Tissue
Neoplasms by Histologic Type
Neoplasms
Neoplastic Syndromes, Hereditary
Neurocutaneous Syndromes
Nervous System Diseases
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases
Genetic Diseases, Inborn
Peripheral Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Neoplasms
Nervous System Neoplasms